Quebec City, April 26, 2016 – TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, will report its first quarter 2016 financial results ended March 31, 2016 via press release on Wednesday, May 4, 2016 before the market opens.
TSO3 will also hold its Annual General and Special Meeting of Shareholders at 10:30 a.m. Eastern Daylight Time on the same day. The meeting will be held at the Musée national des beaux-arts du Québec in Quebec City. TSO3 President and CEO R.M. (Ric) Rumble and CFO Glen Kayll will host the meeting, where management will also discuss its first quarter 2016 financial results and provide an operational update, followed by a question and answer period.
The meeting will be webcast live and available for replay at: http://event.on24.com/r.htm?e=1150732&s=1&k=3DFE465AE18FD41AF931DADAA9BD8D10 and via the Investors section of the company’s website at www.tso3.com. A replay of the meeting will be available on the same day through August 2, 2016.
Founded in 1998, TSO3 is committed to improving the standard of healthcare sterile reprocessing by providing breakthrough sterilization systems, related consumable supplies and accessories for heat-sensitive medical devices. TSO3 designs products for sterile processing areas in the hospital environment that offer an advantageous replacement solution to other low-temperature sterilization processes currently used in hospitals. It also offers services related to the maintenance of sterilization equipment and compatibility testing of medical devices with such processes.
For more information about TSO3, visit the company’s web site at www.tso3.com.
The statements in this release and oral statements made by representatives of TSO3 relating to matters that are not historical facts (including, without limitation, those regarding the timing or outcome of TSO3’s sales, business or operations) are forward-looking statements that involve certain risks, uncertainties and hypotheses, including, but not limited to, general business and economic conditions, the condition of the financial markets, the ability of TSO3 to obtain financing on favourable terms and other risks and uncertainties.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities, in any jurisdiction in which such offer, solicitation or sale would be unlawful.
The TSX has neither approved nor disapproved the information contained herein and accepts no responsibility for it.
-30-Back to Posts